Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BL-M09D1 in Advanced Gynecological Malignancies and Solid Tumors
NCT07769229Phase 2Not yet recruiting
- Sponsor
- Biokin Pharmaceutical
- Start
- Aug 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of BL-M09D1 in Gynecologic cancer, solid tumor, sponsored by Biokin Pharmaceutical. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
BL-M09D1
03
Conditions
Gynecologic cancersolid tumor
Beyond the preview
Go deeper on NCT07769229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07769229.